| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/30/2008 | CN101229133A Omeprazole sodium freeze-dried powder injection and preparing method thereof |
| 07/30/2008 | CN101229131A Novel type nanometer particle preparation capable of reducing gastroenteritic toxicity of camptothecin medicines |
| 07/30/2008 | CN101229130A Isomorellic acid polylactic acid nano particle preparation and preparing method thereof |
| 07/30/2008 | CN101229128A Cefepime hydrochloride powder injection and preparing method thereof |
| 07/30/2008 | CN101229127A Liposome preparation |
| 07/30/2008 | CN101229124A Ivermectin polylactic acid nano particle antibiotic medicine and preparing method thereof |
| 07/30/2008 | CN101229123A Praziquantel long-acting sustained release injection and preparing method thereof |
| 07/30/2008 | CN101229122A Zanamivir nasal in situ jellies with phase variation property and preparing method thereof |
| 07/30/2008 | CN101229121A Penciclovir microemulsion gel preparation and preparing method thereof |
| 07/30/2008 | CN101229120A Sustained release implant for treating solid tumors |
| 07/30/2008 | CN101229119A Sustained release ocular implant for treating solid tumors |
| 07/30/2008 | CN101229118A Thermostatic sustained release injection containing topoisomerase inhibitor and preparing method thereof |
| 07/30/2008 | CN101229117A Thermostatic sustained release injection containing phosphatidylinositol 3-genistein inhibitor and preparing method thereof |
| 07/30/2008 | CN100406890C 带有聚合物壳的纳米颗粒 Nanoparticles with a polymer shell |
| 07/30/2008 | CN100406065C Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
| 07/30/2008 | CN100406063C External-applied ointment used for treating thyropathy, and its preparing method |
| 07/30/2008 | CN100406021C Breviscapine B injection preparation and its preparing method |
| 07/30/2008 | CN100406015C Estradiol metabolites for the treatment of pulmonary hypertension |
| 07/30/2008 | CN100406010C Antitumor agents and process for producing the same |
| 07/30/2008 | CN100406008C Pharmaceutical composition comprising lumiracoxib |
| 07/30/2008 | CN100406004C Vaccine composition and method of using same |
| 07/29/2008 | US7405320 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 07/29/2008 | US7405266 having terminal carboxylic acid or carboxylic acid derivative group that is sterically hindered by an alkyl or aryl group on the alpha-carbon, which enables greater control of the rate of hydrolytic degradation of polymer derivatives; solvent precipitation; biodrug conjugates |
| 07/29/2008 | US7405241 Administering nitrous oxide or xenon or donors thereof along with oxygen, nitrogen, and/or argon; stroke therapy; neuroprotectants |
| 07/29/2008 | US7405238 Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| 07/29/2008 | US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma |
| 07/29/2008 | US7405190 providing a starting mixture comprising an alk(en)yl polyglycoside, and one or more fatty alcohols, reacting starting mixture with a compound selected from omega -halocarboxylic acids, omega -halocarboxylic acid salts, omega -halocarboxylic acid esters or mixture to perform esterification |
| 07/29/2008 | US7405077 Sperm protein 17 for the diagnosis and treatment of cancer |
| 07/29/2008 | US7404965 Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 07/29/2008 | US7404964 Complex of antibiotic and fatty acid; sustained release; extended release time, maximum stability and efficacy, reduced toxicity, maximum reproducibility in preparation, and the elimination of unwanted physical, biochemical, or toxicological effects introduced by undesirable matrix materials |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | CA2391406C Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients |
| 07/29/2008 | CA2381729C Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 07/29/2008 | CA2377614C Anesthetic composition for intravenous injection comprising propofol |
| 07/29/2008 | CA2376303C Stabilized vitamin c formulations |
| 07/29/2008 | CA2374442C Silicone gel containing salicylic acid |
| 07/29/2008 | CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/29/2008 | CA2352149C Solid lipidic nanospheres suitable to a fast internalization into cells |
| 07/29/2008 | CA2344672C Expandable gastroretentive therapy system having a prolonged gastric residence time |
| 07/29/2008 | CA2336799C Improved stable topical ascorbic acid compositions |
| 07/29/2008 | CA2331337C Site specific protein modification by mutagenesis |
| 07/29/2008 | CA2328950C Piperidinopyrimidine derivatives for topical application |
| 07/29/2008 | CA2324077C Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 07/29/2008 | CA2305597C Affinity markers for human serum albumin |
| 07/29/2008 | CA2295628C Stable formulations comprising a nucleotide and a freeze drying additive |
| 07/29/2008 | CA2291685C Pharmaceutical product for the detection of helicobacter pylori-induced gastrointestinal disorder |
| 07/29/2008 | CA2285909C Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same |
| 07/29/2008 | CA2272732C Hemorrhoidal treatment composition |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2254914C Methods of terminal sterilization of biological products |
| 07/29/2008 | CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 07/29/2008 | CA2220223C High purity carnosic acid from rosemary and sage extracts by ph-controlled precipitation |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2207144C A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof |
| 07/29/2008 | CA2203033C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2183471C Method and device for the provocation of air passage narrowing and/or the induction of sputum |
| 07/29/2008 | CA2110490C Drug delivery systems comprising gas-filled liposomes at least 90% devoid of liquid in their interior |
| 07/24/2008 | WO2008089426A2 Methods and compositions for the delivery of a therapeutic agent |
| 07/24/2008 | WO2008089403A2 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 07/24/2008 | WO2008089339A2 Oligosaccharide conjugates for cellular targeting |
| 07/24/2008 | WO2008089272A1 Formulations for cancer treatment |
| 07/24/2008 | WO2008089258A2 Drug eluting medical device using polymeric therapeutics |
| 07/24/2008 | WO2008089257A2 Drug eluting medical device using polymeric therapeutics with transglutaminase substrates |
| 07/24/2008 | WO2008089256A2 Polymeric therapeutics |
| 07/24/2008 | WO2008089248A2 Amphiphilic substances and triggered liberation from lipid vesicles |
| 07/24/2008 | WO2008088983A1 PEGYLATED Aβ FAB |
| 07/24/2008 | WO2008088658A2 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites |
| 07/24/2008 | WO2008088117A1 Composition for promoting bone regeneration and restoration |
| 07/24/2008 | WO2008088039A1 Stabilized medicinal composition containing donepezil, method of producing the same and method for stabilization |
| 07/24/2008 | WO2008088037A1 Finely particulate medicinal preparation |
| 07/24/2008 | WO2008087909A1 Particles for medical use, particles for analysis, and process for production of both |
| 07/24/2008 | WO2008087882A1 Intragastric floating-type levodopa sustained-release preparation |
| 07/24/2008 | WO2008087803A1 Liposome preparation for iontophoresis having antioxidant component encapsulated therein |
| 07/24/2008 | WO2008087326A2 Novel powder polymer containing a surface-active monomer, preparation method thereof and use of same as a thickening agent |
| 07/24/2008 | WO2008087190A2 Use of peptides in combination with surgical intervention for the treatment of obesity |
| 07/24/2008 | WO2008087121A1 Use of a surfactant for the preparation of a formulation for the treatment of adipose dieseases |
| 07/24/2008 | WO2008087094A1 Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases |
| 07/24/2008 | WO2008087076A1 Pharmaceutical composition of improved stability containing taxane derivatives |
| 07/24/2008 | WO2008087034A2 Cyclodextrin formulations |
| 07/24/2008 | WO2008086716A1 Layered double hydroxide complex inserted by dipeptiven and the preparation method thereof |
| 07/24/2008 | WO2008068427A3 Anti-microorganism terpenic composition |
| 07/24/2008 | WO2008060359A3 Biodegradable ocular implants and methods for treating ocular conditions |
| 07/24/2008 | WO2008060356A3 Methods and compositions for gene therapy |
| 07/24/2008 | WO2008057163A3 Preparation of functional gel particles with a dual crosslink network |
| 07/24/2008 | WO2008053250A3 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser |
| 07/24/2008 | WO2008043825A3 Pharmaceutical anti-infective composition for inhalation. |
| 07/24/2008 | WO2007149560A9 Fermentation and purification of actinomadura chromoprotein and related species |
| 07/24/2008 | WO2007122511A3 Antibody-rnase-conjugate |
| 07/24/2008 | WO2007068906A3 Production of conjugates |
| 07/24/2008 | WO2007053533A8 Sodium chloride solution for drug reconstitution or dilution |
| 07/24/2008 | WO2007043050A3 Bioconjugates comprising sulfated polysaccharides and their uses |
| 07/24/2008 | WO2006116107A3 Immunoliposome composition for targeting to a her2 cell receptor |
| 07/24/2008 | WO2006096207A3 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 07/24/2008 | US20080176962 Methods and compositions for identifying cellular genes exploited by viral pathogens |
| 07/24/2008 | US20080176960 Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 07/24/2008 | US20080176959 Biodegradable polyphosphates complex for controlled release of bioactive substances and related methods |
| 07/24/2008 | US20080176958 Cyclodextrin-based polymers for therapeutics delivery |
| 07/24/2008 | US20080176820 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro |
| 07/24/2008 | US20080176802 Methods of Use for Conjugated Exendin Peptides |